BIIB vs LLY
Biogen Inc · Eli Lilly and Company
Relative return (rebased to 100)
Key stats
| Metric | BIIB | LLY |
|---|---|---|
| Price | $253.25 | $1,432.29 |
| Market Cap | $37.44B | $1.35T |
| P/E | 28.95 | 65.28 |
| P/B | 1.98 | 33.46 |
| P/S | 3.78 | 20.67 |
| ROE | 6.8% | 51.3% |
| Net Margin | 13.1% | 31.7% |
| Gross Margin | 117.7% | — |
| Revenue Growth | 2.2% | 44.7% |
| Dividend Yield | — | 0.43% |
| EPS | $8.75 | $21.94 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.